How New FDA Guidance Project Optimus May Affect Future of Oncology Clinical Trials, Drug Pipeline
August 16th 2021Julie Bullock, VP, global head of clinical pharmacology and translational medicine at Certara, discusses the FDA’s new guidance Project Optimus, which addresses issues relating to dose optimization in clinical trials assessing oncology drugs.
Watch
Pharmacist Medication Insights: Darzalex Faspro for Multiple Myeloma
August 16th 2021Daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen) was approved in July in combination with pomalidomide and dexamethasone for the treatment of patients with multiple myeloma following their first or subsequent relapse.
Watch
Pharmacy Focus Episode 29: The Legal Prescription: What to Know About State Boards of Pharmacy
August 13th 2021The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.
Listen
Immunotherapy May Be Effective In Certain Patients With Metastatic Colorectal Cancer
August 12th 2021Patients with microsatellite stable (MSS) colorectal cancer, which represents 95% of all metastatic colorectal cancer cases, are more responsive to checkpoint blockade immunotherapy if the patient’s tumors have not spread to the liver.
Read More
Booster Shots for mRNA COVID-19 Vaccines Offer Improved Protection From Variants of Concern
August 12th 2021The investigators found that antibodies generated by a single dose of the Pfizer-BioNTech vaccine was less effective at neutralizing variants of concern, but the second dose dramatically increased responses to virus variants.
Read More